OMIA group 2493
Alzheimer disease, PSEN1-related
The chain reaches the human disease Alzheimer disease 3, which Mondo defines as: “Alzheimer's disease with an early onset (starts before the age of 65). It is caused by mutations in the PSEN1 gene.”
The chain
From the animal disease to the drugs. The page shows what each step found and where the chain stopped. It does not say whether the animal is a model of a human disease.
-
Animal disease
Reached
OMIA records it in 3 species entries marked as a defect.
-
Human disease
Reached
1 Mondo disease.
-
Human gene
Reached
1 human gene.
-
Target evidence
Reached
1 Open Targets association, with a best score of 0.83.
-
Drugs
Reached
6 ChEMBL drugs, 1 approved. None has been tested for this disease.
Natural-model score
How complete and how well supported the chain to each human disease is, out of 100, by stated rules. It does not say that the animal is a validated model of the human disease. How the score works.
41.7 out of 100
| Part | Computed from | Points |
|---|---|---|
| Target evidence | Open Targets score of 0.83 | 29.2 of 35 |
| Drugs | Drugs act on its genes, but no drug has been tested for this disease | 2.5 of 25 |
| Ortholog | No gene of a naturally occurring entry reaches a human gene | 0.0 of 20 |
| Both routes | Both routes found this disease | 10.0 of 10 |
| Species | 0 naturally occurring species entries marked as a defect. 3 genetically engineered entries are not counted | 0.0 of 10 |
Species
The chain follows only the species entries that OMIA marks as a defect.
| Species | Scientific name | OMIA entry | A defect |
|---|---|---|---|
| crab-eating macaque Genetically engineered, not naturally occurring. Not counted in the score. | Macaca fascicularis | OMIA:002493-9541 | Yes |
| pig Genetically engineered, not naturally occurring. Not counted in the score. | Sus scrofa | OMIA:002493-9823 | Yes |
| white-tufted-ear marmoset Genetically engineered, not naturally occurring. Not counted in the score. | Callithrix jacchus | OMIA:002493-9483 | Yes |
Genes
Each gene OMIA records for a species entry, and the human gene it reaches through Ensembl's orthologs.
| Species | Animal gene | Human gene | Ortholog |
|---|---|---|---|
| crab-eating macaque | PSEN1 presenilin 1 NCBI Gene 102138674 | PSEN1 Ensembl | one to one |
| pig | PSEN1 presenilin 1 NCBI Gene 780411 | PSEN1 Ensembl | one to one |
| white-tufted-ear marmoset | PSEN1 presenilin 1 NCBI Gene 100401034 | PSEN1 Ensembl | one to one |
Human diseases
Two routes lead from an OMIA group to a Mondo human disease: OMIA's own Mondo link, and the group's OMIM numbers through Mondo's cross-references.
- OMIA's own Mondo link: found a disease.
- OMIA's OMIM numbers: found a disease.
| Mondo disease | Name | Found by |
|---|---|---|
| MONDO:0011913 | Alzheimer disease 3 Alzheimer's disease with an early onset (starts before the age of 65). It is caused by mutations in the PSEN1 gene. | Both routes |
Target evidence
Each Open Targets association between one of the group's human genes and one of its human diseases, with its overall score and the score for each kind of evidence.
| Human gene | Human disease | Score | Evidence | Kinds of evidence |
|---|---|---|---|---|
| PSEN1 | Alzheimer disease 3 | 0.83 | 622 | Genetic association 0.98 Genetic literature 0.88 Animal model 0.40 Literature 0.04 |
Drugs
Drugs act on PSEN1, but none has been tested for this disease.
| Drug | Acts on | How | Latest stage | Tested for this disease |
|---|---|---|---|---|
| Nirogacestat | PSEN1 | inhibitor | Approved | No |
| Semagacestat | PSEN1 | inhibitor | Phase 3 | No |
| Tarenflurbil | PSEN1 | modulator | Phase 3 | No |
| Avagacestat | PSEN1 | inhibitor | Phase 2 | No |
| Rg-4733 | PSEN1 | inhibitor | Phase 2 | No |
| Begacestat | PSEN1 | inhibitor | Phase 1 | No |
The drug data is ChEMBL's, under CC BY-SA 3.0, and came through Open Targets release 26.09.